Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
ID
CAS
2097132-94-8
Purity
95%
Pralsetinib is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer.
Properties
Name
Pralsetinib
Smiles
CO[C@]1(CC[C@H](CC1)C=2N=C(C)C=C(NC=3C=C(C)NN3)N2)C(=O)N[C@@H](C)C=4C=CC(=NC4)N5C=C(F)C=N5
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
BLU-667 | pralsetinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$129
2 mg
$135
5 mg
$147
10 mg
$163
15 mg
$230
20 mg
$296
25 mg
$367
30 mg
$414
35 mg
$461
40 mg
$502
45 mg
$553
50 mg
$594
75 mg
$868
100 mg
$POA
Quantity
1
Total amount
$ 147
BLU-667 | pralsetinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.